AKT1 and renal carcinoma: Additionally, eupatilin increased ROS generation and apoptosis by abrogating MAPK and AKT in renal cancer [8] and increased mitotic cell cycle arrest by inhibiting the AKT and ERK pathways in endometrial cancer cells [7].